Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial - Tawbi, H A; Burgess, M; Bolejack, V (Lancet Oncol, 2017)